Related Experiment Videos
Neuroblastoma: new approaches to diagnosis
J T Kemshead1, L S Lashford, J Garson
1ICRF Oncology Laboratory, Institute of Child Health, London.
Cancer Surveys
|January 1, 1987
Summary
Monoclonal antibodies aid in diagnosing neuroblastoma and identifying metastatic cells. Further research into radioimmunolocalization and targeted therapy is needed for improved patient outcomes.
Area of Science:
- Oncology
- Immunology
- Pediatric Medicine
Background:
- Neuroblastoma is a common childhood cancer.
- Accurate diagnosis is crucial for effective treatment.
- Current diagnostic methods have limitations.
Purpose of the Study:
- To review the diagnostic applications of monoclonal antibodies in neuroblastoma.
- To assess the potential of novel diagnostic approaches.
- To discuss the impact of molecular biology and cytogenetics on neuroblastoma diagnosis and prognosis.
Main Methods:
- Review of existing literature on monoclonal antibody applications.
- Comparison of established and emerging diagnostic techniques.
- Analysis of the role of molecular and cytogenetic tools.
Main Results:
- Monoclonal antibodies are valuable for distinguishing neuroblastoma and detecting bone marrow metastases.
- Radioimmunolocalization and targeted therapy require further investigation.
- Molecular biology and molecular cytogenetics show promise for future diagnosis and prognosis.
Conclusions:
- Monoclonal antibodies are established diagnostic aids for neuroblastoma.
- Emerging molecular techniques will enhance diagnostic accuracy and prognostic assessment.
- Improved diagnostic strategies are expected to lead to better patient stratification and treatment outcomes.